Lilly's combo therapy succeeds in late-stage lung cancer study

REUTERS: Eli Lilly and Co's combination cancer treatment met the main goal of a late-stage clinical trial testing it on patients with a form of lung cancer, the drugmaker announced on Tuesday.

Previously untreated patients with metastatic non-small cell lung cancer taking a combination of Lilly's Cyramza and Roche's erlotinib went longer before their disease started to worsen, study results showed.Lung cancer is the leading cause of cancer death among both men and women, and each year, more people die of lung cancer than of colon, breast, and prostate cancers combined, according to the American Cancer Society.

Cyramza, which made more than US$800 million in revenue for Lilly in 2018, is approved in the United States to treat other forms of cancers, including stomach and another type of lung cancer. The Indianapolis-based drugmaker plans to start global regulatory submissions for its Cyramza combination therapy in mid-2019.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Roche gets European approval for Tecentriq combo vs. lung cancerRoche has received European Commission approval for its Tecentriq drug in combination with Avastin and chemotherapy as an initial treatment for ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Allergan's add-on treatment for depression fails late-stage studiesAllergan Plc said on Wednesday its experimental add-on treatment for major depressive disorder failed to meet the main goals of three late-stage ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Alnylam's gene-silencing drug meets main goal in late-stage studyREUTERS: Alnylam Pharmaceuticals Inc said on Wednesday its gene-silencing drug for treating a rare, painful disease met the main goal in a ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Jeopardy! host Alex Trebek diagnosed with stage 4 pancreatic cancer
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Jeopardy! host Alex Trebek has stage 4 pancreatic cancerAlex Trebek, the beloved host of US game show Jeopardy!, announced on Wednesday that he was diagnosed stage 4 pancreatic cancer. The 78-year-old Canadian said in a video shared on the show's Twitter account that he planned to 'beat the low survival rates for this illness'...
Source: thenewpaper - 🏆 7. / 63 Read more »